SANTOLAMAZZA, CATERINA
 Distribuzione geografica
Continente #
NA - Nord America 773
EU - Europa 260
AS - Asia 57
AF - Africa 6
SA - Sud America 2
Totale 1.098
Nazione #
US - Stati Uniti d'America 773
AT - Austria 74
IT - Italia 72
FI - Finlandia 31
IN - India 30
CN - Cina 21
DE - Germania 17
BG - Bulgaria 16
IE - Irlanda 11
FR - Francia 10
SE - Svezia 9
NL - Olanda 7
TG - Togo 6
RO - Romania 5
TR - Turchia 5
RU - Federazione Russa 3
AR - Argentina 2
GB - Regno Unito 2
UA - Ucraina 2
BE - Belgio 1
SG - Singapore 1
Totale 1.098
Città #
Fairfield 149
Chandler 66
Ashburn 65
Woodbridge 62
Vienna 60
Seattle 56
Wilmington 52
Cambridge 46
Houston 46
Rome 21
Ann Arbor 20
Helsinki 17
Princeton 16
Sofia 16
Plano 15
San Paolo di Civitate 14
Dearborn 13
San Diego 12
Beijing 11
Dublin 11
New York 11
Boston 10
Lawrence 10
Lomé 6
Millbury 6
Andover 4
Falls Church 4
Fremont 4
Istanbul 4
Asheville 2
Bremen 2
Fasano 2
Federal 2
Fisciano 2
Kunming 2
Lucca 2
Paris 2
Perugia 2
Redwood City 2
Roccalumera 2
Rubano 2
San Mateo 2
Sassari 2
Shanghai 2
Varese 2
Washington 2
Brussels 1
Buffalo 1
Chaoyang 1
Chicago 1
Chiusi 1
Des Moines 1
Fuzhou 1
Harbin 1
Konya 1
Laurel 1
Maruggio 1
Nanjing 1
Nanning 1
Norwalk 1
Pordenone 1
Pune 1
Redmond 1
San Francisco 1
Targu Jiu 1
Wuhan 1
Totale 881
Nome #
Cardiopulmonary exercise test in hypertrophic cardiomyopathy 114
Clinical and prognostic impact of chronotropic incompetence in patients with hypertrophic cardiomyopathy 91
Prognostic implications of defibrillation threshold testing in patients with hypertrophic cardiomyopathy 88
QT spatial dispersion and sudden cardiac death in hypertrophic cardiomyopathy. time for reappraisal. 79
Cardiopulmonary exercise test and sudden cardiac death risk in hypertrophic cardiomyopathy 74
Heart failure progression in hypertrophic cardiomyopathy, Possible insights from cardiopulmonary exercise testing 73
Pathogenesis of Target Organ Damage in Hypertension: Role of Mitochondrial Oxidative Stress. 67
null 67
null 56
null 55
Getting to the heart of the matter in a multisystem disorder: Erdheim–Chester disease 54
Preclinical effects of healthy obesity on inappropriate left ventricular mass and systolic function 51
Inadequate RAAS suppression is associated with excessive left ventricular mass and systo-diastolic dysfunction 51
null 47
null 45
Phytochemical Compounds and Protection from Cardiovascular Diseasesa. A State of the Art 40
New therapies for arterial hypertension 37
Does moderate hyperkalemia influence survival in HF? Insights from the MECKI score data base 25
Monotherapy and Dual Combination Therapies Based on Olmesartan: A Comprehensive Strategy to Improve Blood Pressure Control 22
Triple Combination Therapies Based on Olmesartan: A Personalized Therapeutic Approach to Improve Blood Pressure Control 13
Erythropoiesis-stimulating agents in heart failure: Leave it or re-take it? 7
Hypertension in patients with heart failure with reduced ejection fraction 6
Totale 1.162
Categoria #
all - tutte 2.661
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.661


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019137 0 0 0 0 0 0 0 0 0 29 63 45
2019/2020271 42 9 2 13 24 37 39 34 34 19 8 10
2020/202171 6 12 0 4 0 6 2 4 17 12 6 2
2021/2022204 0 14 24 4 27 5 4 23 13 10 42 38
2022/2023224 28 41 31 19 24 19 12 9 19 2 12 8
2023/2024137 11 22 8 27 9 42 1 17 0 0 0 0
Totale 1.162